Poor sense of smell linked to depression
In a study that followed more than 2,000 community-dwelling older adults over eight years, researchers at Johns Hopkins Medicine say they have significant new evidence of a link between decreased sense of smell and the risk of developing late-life depression.
Their findings, published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, do not demonstrate that loss of smell causes depression, but suggest that it may serve as a potent indicator of overall health and well-being.
“We’ve seen repeatedly that a poor sense of smell can be an early warning sign of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, as well as a mortality risk.
“This study underscores its association with depressive symptoms,” said Vidya Kamath, Ph.D., an associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine.
“Additionally, this study explores factors that might influence the relationship between olfaction and depression, including poor cognition and inflammation.”
How the study worked
The study used data gathered from 2,125 participants in a federal government study known as the Health, Aging and Body Composition Study. This cohort was composed of a group of healthy older adults ages 70 to 73 at the start of the eight-year study period in 1997 and 98.
Participants showed no difficulties in walking 0.25 miles, climbing 10 steps or performing normal activities at the start of the study, and were assessed in person annually and by phone every six months. Tests included those for the ability to detect certain odors, depression and mobility assessments.
In 1999, when smell was first measured, 48% of participants displayed a normal sense of smell, 28% showed a decreased sense of smell, known as hyposmia, and 24% had a profound loss of the sense, known as anosmia. Participants with a better sense of smell tended to be younger than those reporting significant loss or hyposmia.
Over follow-up, 25% of participants developed significant depressive symptoms. When analyzed further, researchers found that individuals with decreased or significant loss of smell had an increased risk of developing significant depressive symptoms at longitudinal follow-up than those in the normal olfaction group.
Researchers also identified three depressive symptom “trajectories” in the study group: stable low, stable moderate and stable high depressive symptoms. A poorer sense of smell was associated with an increased chance of a participant falling into the moderate or high depressive symptoms groups, meaning that the worse a person’s sense of smell, the higher their depressive symptoms.
These findings persisted after adjusting for age, income, lifestyle, health factors and use of antidepressant medication.
“Losing your sense of smell influences many aspects of our health and behavior, such as eating enjoyment and sensing spoiled food or noxious gas.
“Now we can see that it may also be an important vulnerability indicator of something in your health gone awry,” Kamath said. “Smell is an important way to engage with the world around us, and this study shows it may be a warning sign for late-life depression.”
How our brains process odors
Humans’ sense of smell is one of two chemical senses. It works through specialized sensory cells called olfactory neurons, which are found in the nose.
These neurons have one odor receptor that picks up molecules released by substances around us, which are then relayed to the brain for interpretation. The higher the concentration of these smell molecules, the stronger the smell, and different combinations of molecules result in different sensations.
Smell is processed in the brain’s olfactory bulb, which is believed to interact closely with the amygdala, hippocampus and other brain structures that regulate and enable memory, decision-making and emotional responses.
The Hopkins researchers say their study suggests that olfaction and depression may be linked through both biological (e.g., altered serotonin levels, brain volume changes) and behavioral (e.g., reduced social function and appetite) mechanisms.
The researchers plan to replicate their findings from this study in more groups of older adults, and examine changes to individuals’ olfactory bulbs to determine if this system is, in fact, altered in those diagnosed with depression.
They also plan to examine if smell can be used in intervention strategies to mitigate the risk of late-life depression.
This work was supported by the National Institute on Aging, the National Institute of Nursing Research, and the Intramural Research Program of the National Institutes of Health: National Institute on Aging.
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences is a peer-reviewed publication of The Gerontological Society of America (GSA), the nation’s oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.
The principal mission of the society — and its 5,500+ members — is to advance the study of aging and disseminate information among scientists, decision makers, and the general public. GSA’s structure also includes a policy institute, the National Academy on an Aging Society.